CCL19 and head and neck neoplasm: The binding of CCR7 and its ligand CCL19 induces chemotactic migration and cytoskeletal rearrangement of target cells, which are involved in a variety of physiological and pathological processes that regulate tumor survival and proliferation, invasion, and metastasis, including leukemia [27] and head and neck tumors [26].